| Tag | Content |
|---|
EnhancerAtlas ID | HS148-07777 |
Organism | Homo sapiens |
Tissue/cell | NHLF |
Coordinate | chr17:74510940-74512320 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr17:74511090-74511105 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_03051 | chr17:74511107-74512036 | Bladder | | SE_09479 | chr17:74510785-74512354 | CD14 | | SE_11207 | chr17:74510641-74512778 | CD20 | | SE_20219 | chr17:74508830-74514648 | CD56 | | SE_22949 | chr17:74508579-74514665 | CD8_primiary | | SE_41105 | chr17:74511151-74512154 | Left_Ventricle | | SE_48771 | chr17:74511207-74512242 | Right_Atrium | | SE_62418 | chr17:74475150-74527312 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I076513 | chr17 | 74509114 | 74514557 |
|
Enhancer Sequence | AAGATCGTAC CACTGCACAC CAGCCTGGGT GGCAGAGCAA GACTCTGTCT CAAAAAAAAA 60
AAAAAAAAAA AAAGAGAGAG AGATGGCCGG GCGCGGTGGC TCACACCTGT AATCCCAGCA 120
TTTTGGGAGG CTGAGGTGGG TGGATCACTG GAGGTCAGGA GTTCAAGACC AGCCTGACCA 180
ACATGGTGAA ACCCCGTTTC TACTATAAAT ACAAAAATTA GCTGGGTGTG GTGGCTCGCC 240
CTGTAGTCCC AGCTACTCAG GAGGCTGAGG CAGGAGAATC ACTTGAACCT GGGAGGCAGA 300
GTGCAGTGAG CTGAGATCAT GCCACTGCAC ACCAGCCTGG GCTATAGAGT GAGACTCTGT 360
CTCACACACA CACACACAAA AAGAAGGCGA GAAGGGGAGC CGGGGGAGAA ATGAGCCTGG 420
AAAGATGGCC CGGGCCAAAT CAGGCGGGCT GGGGAGCCAG GCCAGGACTC TGCTTTCTGT 480
TTGGCTGTGA CTTCAGTAAG CTAGGGCAGG GTTTTGATGG GCCAGGGAGG AGTCCACGCG 540
ATCTGATTCA CACGATAAAA GCATTTCCTG GGCCCTGAGT GGAGACCACA ACGTGGGAGG 600
GCAGAGCGGA GGCCGACGAC TGGGAGGAGG CTTTGCAGTC GCCGGGCGAG ACGATGGCTT 660
TCTTTCCTGG CTCATTTCAC ACTAAACTGG GGACCAGCCA GAAAGCCTTG GGAACTTGTC 720
AGACCCACAT ACGCTGCCAC TGAGTCAACT GCTACTATCA TCCCTGTGTG ACCTGAACCG 780
AAACCCACTC ACTTGCGAAA CTGCTGGAGG CTTCTTCACT AAAACCCATA TGCATGCTAA 840
GATCCTGGCG TAACATAAAA TGTCATGTGC GTGTGCCGCG TAAAATGTGC GTGTGCACAG 900
GAAAACCACT GCCAGTATTT ACAGCAAAAC ACTCACAGTG ACTCTCGGGT GGAGGGACCA 960
CAGGGGACTT TTATTGTCAC AGCCCTGACT TCTGTCCTGC TTCAGACCAG ACTCTCCAAC 1020
CACTTCCTGG ACACCTCCCT TTGTGCTTTT CTTTCCCCCT CAAATTTCCT GCAATGTTTT 1080
TTTTTTTTTT TTCGAGACAG AGTCTTGCTC TGTGACCCAG GCTGGAGTGC AGTGGTGTGA 1140
TCTCGGCTCA CTGCAACCTT CGCCCCTGGG TTTTTAAGTA ATTCTCCTAC CTCAGTCTCC 1200
TGAGTAGCTG GGATTACTGG CGCCTGCCAC CACGCCCAGC TAATTTTTGT ATTTTTAGTA 1260
GAGATGGGGT TTCACCATGT TGTCCAGGCT GGTCTCGAAC TCCTGACCTT GTGATCCGCC 1320
CGCCTTGCCC TCCTGAAGTG CTGGGATTAC AGGCCTGAGC CACCGCACCC GGCTGCCTTT 1380
|
